Selected from pub med for the period July 1, 2006 through June 30, 2007

descargar 100.7 Kb.
títuloSelected from pub med for the period July 1, 2006 through June 30, 2007
fecha de publicación22.10.2015
tamaño100.7 Kb.
tipoDocumentos > Ley > Documentos
  1   2   3   4   5

Selected from PUB MED for the period July 1, 2006 through June 30, 2007

Criteria: Asthma, All Fields, items with abstracts, human, clinical trial and

Asthma AND systematic, All Fields, items with abstracts, human
1. Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma. Am J Respir Crit Care Med 2007;175:235-42.

2. Abreu Gonzalez J, Hernandez Garcia C, Abreu Gonzalez P, Martin Garcia C, Jimenez A. [Effect of intravenous magnesium sulfate on chronic obstructive pulmonary disease exacerbations requiring hospitalization: a randomized placebo-controlled trial]. Arch Bronconeumol 2006;42:384-7.

3. Accordini S, Bugiani M, Arossa W, et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol 2006;141:189-98.

4. Adams NP, Jones PW. The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviews. Respir Med 2006;100:1297-306.

5. Adamzik M, Groeben H, Farahani R, Lehmann N, Peters J. Intravenous lidocaine after tracheal intubation mitigates bronchoconstriction in patients with asthma. Anesth Analg 2007;104:168-72.

6. Ait-Khaled N, Enarson DA, Bencharif N, et al. Treatment outcome of asthma after one year follow-up in health centres of several developing countries. Int J Tuberc Lung Dis 2006;10:911-6.

7. Akerman MJ, Yaegashi M, Khiangte Z, Murugan AT, Abe O, Marmur JD. Bronchodilator effect of infused B-type natriuretic peptide in asthma. Chest 2006;130:66-72.

8. Akobeng AK, Heller RF. Assessing the population impact of low rates of breast feeding on asthma, coeliac disease and obesity: the use of a new statistical method. Arch Dis Child 2007;92:483-5.

9. Aldington S, Williams M, Weatherall M, Beasley R. Duration of action of the salmeterol/fluticasone combination inhaler administered in the evening: a randomized controlled trial in childhood asthma. Respirology 2006;11:638-42.

10. Altamimi S, Robertson G, Jastaniah W, et al. Single-dose oral dexamethasone in the emergency management of children with exacerbations of mild to moderate asthma. Pediatr Emerg Care 2006;22:786-93.

11. Altunc U, Pittler MH, Ernst E. Homeopathy for childhood and adolescence ailments: systematic review of randomized clinical trials. Mayo Clin Proc 2007;82:69-75.

12. Alvarez GG, Fitzgerald JM. A systematic review of the psychological risk factors associated with near fatal asthma or fatal asthma. Respiration 2007;74:228-36.

13. Amirav I, Yacobov R, Luder AS. Formoterol turbuhaler is as effective as salbutamol diskus in relieving adenosine-induced bronchoconstriction in children. J Aerosol Med 2007;20:1-6.

14. Andreasyan K, Ponsonby AL, Dwyer T, Dear K, Cochrane J. Infant feeding and childhood atopy: does early introduction of non-milk fluids matter? Pediatr Allergy Immunol 2007;18:250-7.

15. Anguita JL, Palacios L, Ruiz-Valenzuela L, et al. An occupational respiratory allergy caused by Sinapis alba pollen in olive farmers. Allergy 2007;62:447-50.

16. Anthracopoulos MB, Liolios E, Panagiotakos DB, Triantou K, Priftis KN. Prevalence of asthma among schoolchildren in Patras, Greece: four questionnaire surveys during 1978-2003. Arch Dis Child 2007;92:209-12.

17. Antonicelli L, Micucci C, Voltolini S, et al. Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin Exp Allergy 2007;37:954-60.

18. Antonicelli L, Micucci C, Voltolini S, et al. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma. Allergy 2007;62:1064-70.

19. Armentia A, Bartolome B, Puyo M, et al. Tobacco as an allergen in bronchial disease. Ann Allergy Asthma Immunol 2007;98:329-36.

20. Arnlind MH, Nokela M, Rehnberg C, Jonsson EW. The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care. J Asthma 2006;43:585-91.

21. Arnold SR, Bush AJ. Decline in inappropriate antibiotic use over a decade by pediatricians in a Tennessee community. Ambul Pediatr 2006;6:225-9.

22. Arshad SH, Bateman B, Sadeghnejad A, Gant C, Matthews SM. Prevention of allergic disease during childhood by allergen avoidance: the Isle of Wight prevention study. J Allergy Clin Immunol 2007;119:307-13.

23. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43.

24. Aslan S, Kandis H, Akgun M, Cakir Z, Inandi T, Gorguner M. The effect of nebulized NaHCO3 treatment on "RADS" due to chlorine gas inhalation. Inhal Toxicol 2006;18:895-900.

25. Backer V, Nepper-Christensen S, Nolte H. Quality of care in patients with asthma and rhinitis treated by respiratory specialists and primary care physicians: a 3-year randomized and prospective follow-up study. Ann Allergy Asthma Immunol 2006;97:490-6.

26. Bakhireva LN, Jones KL, Schatz M, et al. Safety of leukotriene receptor antagonists in pregnancy. J Allergy Clin Immunol 2007;119:618-25.

27. Barnes ML, Menzies D, Fardon TC, Burns P, Wilson AM, Lipworth BJ. Combined mediator blockade or topical steroid for treating the unified allergic airway. Allergy 2007;62:73-80.

28. Basibuyuk T, Ozaydin E, Cengizlier R. Nasal cytology in the diagnosis and treatment of sinusitis in atopic and nonatopic children. J Otolaryngol 2006;35:255-60.

29. Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJ, Pedersen SE. The correlation between asthma control and health status: the GOAL study. Eur Respir J 2007;29:56-62.

30. Batra J, Pratap Singh T, Mabalirajan U, Sinha A, Prasad R, Ghosh B. Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels. Thorax 2007;62:16-22.

31. Batra J, Sharma SK, Ghosh B. Arylamine N-acetyltransferase gene polymorphisms: markers for atopic asthma, serum IgE and blood eosinophil counts. Pharmacogenomics 2006;7:673-82.

32. Bavbek S, Dursun AB, Dursun E, Eryilmaz A, Misirligil Z. Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study. Int Arch Allergy Immunol 2007;142:64-9.

33. Beach J, Russell K, Blitz S, et al. A systematic review of the diagnosis of occupational asthma. Chest 2007;131:569-78.

34. Bell JS, Vaananen M, Ovaskainen H, Narhi U, Airaksinen MS. Providing patient care in community pharmacies: practice and research in Finland. Ann Pharmacother 2007;41:1039-46.

35. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007;356:685-96.

36. Bender BG, Long A, Parasuraman B, Tran ZV. Factors influencing patient decisions about the use of asthma controller medication. Ann Allergy Asthma Immunol 2007;98:322-8.

37. Berger WE, Milgrom H, Chervinsky P, et al. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma. Ann Allergy Asthma Immunol 2006;97:672-80.

38. Bernardini R, Campodonico P, Burastero S, et al. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study. Curr Med Res Opin 2006;22:1515-22.

39. Bethke TD, Bohmer GM, Hermann R, et al. Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor. J Clin Pharmacol 2007;47:26-36.

40. Bethke TD, Giessmann T, Westphal K, et al. Roflumilast, a once-daily oral phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled salbutamol when co-administered in healthy subjects. Int J Clin Pharmacol Ther 2006;44:572-9.

41. Bezarashvili B. [Effect of plaferon in children treated for bronchial asthma]. Georgian Med News 2006:53-6.

42. Bhogal S, Zemek R, Ducharme FM. Written action plans for asthma in children. Cochrane Database Syst Rev 2006;3:CD005306.

43. Bisgaard H, Le Roux P, Bjamer D, Dymek A, Vermeulen JH, Hultquist C. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest 2006;130:1733-43.

44. Bleecker ER, Yancey SW, Baitinger LA, et al. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. J Allergy Clin Immunol 2006;118:809-16.

45. Blumberga G, Groes L, Haugaard L, Dahl R. Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics. Allergy 2006;61:843-8.

46. Boot JD, de Haas S, Tarasevych S, et al. Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma. Am J Respir Crit Care Med 2007;175:450-7.

47. Boot JD, de Kam ML, Mascelli MA, et al. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy 2007;62:378-84.

48. Borderias L, Mincewicz G, Paggiaro PL, et al. Asthma control in patients with asthma and allergic rhinitis receiving add-on montelukast therapy for 12 months: a retrospective observational study. Curr Med Res Opin 2007;23:721-30.

49. Boutet K, Malo JL, Ghezzo H, Gautrin D. Airway hyperresponsiveness and risk of chest symptoms in an occupational model. Thorax 2007;62:260-4.

50. Brachlow AE, Ness KK, McPheeters ML, Gurney JG. Comparison of indicators for a primary care medical home between children with autism or asthma and other special health care needs: National Survey of Children's Health. Arch Pediatr Adolesc Med 2007;161:399-405.

51. Bradshaw LM, Barber CM, Davies J, Curran AD, Fishwick D. Work-related asthma symptoms and attitudes to the workplace. Occup Med (Lond) 2007;57:30-5.

52. Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res 2005;6:144.

53. Brindicci C, Ito K, Barnes PJ, Kharitonov SA. Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest 2007;131:1353-62.

54. Brown MD, Reeves MJ, Meyerson K, Korzeniewski SJ. Randomized trial of a comprehensive asthma education program after an emergency department visit. Ann Allergy Asthma Immunol 2006;97:44-51.

55. Brown RH, Pearse DB, Pyrgos G, Liu MC, Togias A, Permutt S. The structural basis of airways hyperresponsiveness in asthma. J Appl Physiol 2006;101:30-9.

56. Bruce CT, Zhao D, Yates DH, Thomas PS. AMP challenge induces a decrease in FE(NO) in asthmatic subjects modulated by nedocromil. Eur J Clin Invest 2006;36:899-905.

57. Bruzzese JM, Evans D, Wiesemann S, et al. Using school staff to establish a preventive network of care to improve elementary school students' control of asthma. J Sch Health 2006;76:307-12.

58. Buchele G, Rzehak P, Weinmayr G, et al. Assessing bronchial responsiveness to hypertonic saline using the stepwise protocol of Phase Two of the International Study of Asthma and Allergies in Childhood (ISAAC II). Pediatr Pulmonol 2007;42:131-40.

59. Buist AS, Vollmer WM, Wilson SR, Frazier EA, Hayward AD. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med 2006;174:1077-87.

60. Bullens DM, Truyen E, Coteur L, et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006;7:135.

61. Burkhart PV, Rayens MK, Revelette WR, Ohlmann A. Improved health outcomes with peak flow monitoring for children with asthma. J Asthma 2007;44:137-42.

62. Burki NK, Alam M, Lee LY. The pulmonary effects of intravenous adenosine in asthmatic subjects. Respir Res 2006;7:139.

63. Cai C, Yang J, Hu S, Zhou M, Guo W. Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma. Lung 2007;185:105-12.

64. Calamita Z, Saconato H, Pela AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy 2006;61:1162-72.

65. Can M, Yuksel B, Demirtas S, Tomac N. The effect of montelukast on soluble interleukin-2 receptor and tumor necrosis factor alpha in pediatric asthma. Allergy Asthma Proc 2006;27:383-6.

66. Capra V, Thompson MD, Sala A, Cole DE, Folco G, Rovati GE. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. Med Res Rev 2007;27:469-527.

67. Capraz F, Kunter E, Cermik H, Ilvan A, Pocan S. The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics. Lung 2007;185:89-96.

68. Carlsten C, Aitken ML, Hallstrand TS. Safety of sputum induction with hypertonic saline solution in exercise-induced bronchoconstriction. Chest 2007;131:1339-44.

69. Celikel S, Karakaya G, Yurtsever N, Sorkun K, Kalyoncu AF. Bee and bee products allergy in Turkish beekeepers: determination of risk factors for systemic reactions. Allergol Immunopathol (Madr) 2006;34:180-4.

70. Chakraborti A, Lodha R, Pandey RM, Kabra SK. Randomized controlled trial of ipratropium bromide and salbutamol versus salbutamol alone in children with acute exacerbation of asthma. Indian J Pediatr 2006;73:979-83.

71. Chan CK, Kuo ML, Shen JJ, See LC, Chang HH, Huang JL. Ding Chuan Tang, a Chinese herb decoction, could improve airway hyper-responsiveness in stabilized asthmatic children: a randomized, double-blind clinical trial. Pediatr Allergy Immunol 2006;17:316-22.

72. Chan DS, Callahan CW, Hatch-Pigott VB, et al. Internet-based home monitoring and education of children with asthma is comparable to ideal office-based care: results of a 1-year asthma in-home monitoring trial. Pediatrics 2007;119:569-78.

73. Chan IH, Tang NL, Leung TF, et al. Association of prostaglandin-endoperoxide synthase 2 gene polymorphisms with asthma and atopy in Chinese children. Allergy 2007;62:802-9.

74. Charles T, Quinn D, Weatherall M, Aldington S, Beasley R, Holt S. An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. J Allergy Clin Immunol 2007;119:811-6.

75. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006;174:127-33.

76. Cheng YX, Foster B, Holland SM, et al. CD2 identifies a monocyte subpopulation with immunoglobulin E-dependent, high-level expression of Fc epsilon RI. Clin Exp Allergy 2006;36:1436-45.

77. Chinchilli VM. General principles for systematic reviews and meta-analyses and a critique of a recent systematic review of long-acting beta-agonists. J Allergy Clin Immunol 2007;119:303-6.

78. Chinn S, Downs SH, Anto JM, et al. Incidence of asthma and net change in symptoms in relation to changes in obesity. Eur Respir J 2006;28:763-71.

79. Choudhry S, Burchard EG, Borrell LN, et al. Ancestry-environment interactions and asthma risk among Puerto Ricans. Am J Respir Crit Care Med 2006;174:1088-93.

80. Clifford S, Barber N, Elliott R, Hartley E, Horne R. Patient-centred advice is effective in improving adherence to medicines. Pharm World Sci 2006;28:165-70.

  1   2   3   4   5


Selected from pub med for the period July 1, 2006 through June 30, 2007 iconOtoño 2007 a med-1 Occupational Health System publication promoting...

Selected from pub med for the period July 1, 2006 through June 30, 2007 iconRelación de libros de texto. Curso escolar 2006-2007

Selected from pub med for the period July 1, 2006 through June 30, 2007 iconCiclos formativos de grado superior curso 2006-2007

Selected from pub med for the period July 1, 2006 through June 30, 2007 iconUn buen invento Entregados los premios Best Of al Turismo Vitivinícola 2006-2007

Selected from pub med for the period July 1, 2006 through June 30, 2007 iconAsunto: Comunicando índice absentismo contingencias comunes julio 2006– junio 2007

Selected from pub med for the period July 1, 2006 through June 30, 2007 iconInvestigacióN : «El Teatro Comunitario y su incidencia en la escena...
«Taller de Investigación acerca de las relaciones entre teatro callejero, comparsa, palabra y fiesta (2006 )»; «El significado del...

Selected from pub med for the period July 1, 2006 through June 30, 2007 iconCafeteria y pub ambientado en los 70´

Selected from pub med for the period July 1, 2006 through June 30, 2007 iconFirst Grade Period I

Selected from pub med for the period July 1, 2006 through June 30, 2007 iconFirst Grade Period I

Selected from pub med for the period July 1, 2006 through June 30, 2007 iconInstrucción Fiscalía General del Estado núm. 2/2006, de 15 marzo (jur 2006\94040)


Todos los derechos reservados. Copyright © 2015